Skip to content
★ Sign in to follow
MS

Michael Sweeney MD

Executive
Depomed Inc
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€262k

Latest filing published 04 Dec 2013 for DEPOMED INC, €26k.

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

No signal scores available.

Michael Sweeney MD: trading record in brief

Michael Sweeney MD appears in our data through filings on Depomed Inc shares, published by SEC (Form 4). Between 14 June 2011 and 2 December 2013, the trades on record add up to 6 filings.

Sales make up the whole of the open-market record (5 sales, €262k). The rest of the record consists of 1 option exercise. So far in 2013, the count stands at no purchases and 1 sale.

On 4 December 2013 came the latest disclosure, an open-market sale for €26k in Depomed Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael Sweeney MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▼
    CMO and VP, R&DExecutivesDepomed Inc
    35,868 USD0SEC
    4,270 shares@ US$8.40Common StockSEC:0001179110-13-017419:0
  • ◇
    CMO and VP, R&DExecutivesDepomed Inc
    73,200 USD0SEC
    40,000 shares@ US$1.83Common StockSEC:0001179110-12-017723:0
  • ▼
    CMO and VP, R&DExecutivesDepomed Inc
    256,137 USD0SEC
    43,635 shares@ US$5.87Comon StockSEC:0001179110-12-017723:1
  • ▼
    CMO and VP, R&DExecutivesDepomed Inc
    8,182 USD0SEC
    1,418 shares@ US$5.77Common StockSEC:0001179110-12-017082:0
  • ▼
    CMO and VP, R&DExecutivesDepomed Inc
    36,565 USD0SEC
    4,470 shares@ US$8.18Common StockSEC:0001179110-11-009694:0
  • ▼
    CMO and VP, R&DExecutivesDepomed Inc
    11,634 USD0SEC
    1,385 shares@ US$8.40Common StockSEC:0001179110-11-009694:1

6 of 6 declarations